These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Rhabdomyolysis and HMG-CoA reductase inhibitors. Omar MA; Wilson JP; Cox TS Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861 [TBL] [Abstract][Full Text] [Related]
12. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103 [TBL] [Abstract][Full Text] [Related]
13. Rhabdomyolysis in association with simvastatin and amiodarone. Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169 [TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin. Page SR; Yee KC Intern Med J; 2014 Jul; 44(7):690-3. PubMed ID: 25041770 [TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia. Kostapanos MS; Milionis HJ; Elisaf MS Am J Cardiovasc Drugs; 2010; 10(1):11-28. PubMed ID: 20104931 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin-induced myopathy, the role of interaction with diltiazem and genetic predisposition. Hu M; Mak VW; Tomlinson B J Clin Pharm Ther; 2011 Jun; 36(3):419-25. PubMed ID: 21545622 [TBL] [Abstract][Full Text] [Related]
18. Muscle toxicity with statins. Hedenmalm K; Alvan G; Ohagen P; Dahl ML Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):223-31. PubMed ID: 20014178 [TBL] [Abstract][Full Text] [Related]